These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 32460190)

  • 1. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
    Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
    Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells.
    Kun-Peng Z; Chun-Lin Z; Xiao-Long M; Lei Z
    J Cell Physiol; 2019 May; 234(5):6927-6939. PubMed ID: 30204936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
    Meng X; Ma J; Wang B; Wu X; Liu Z
    J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
    Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
    Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
    Zhou B; Li L; Li Y; Sun H; Zeng C
    Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
    Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
    J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
    Zhi XH; Jiang K; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
    Hu T; Fei Z; Su H; Xie R; Chen L
    Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
    Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
    J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis.
    Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y
    Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.
    Li H; Wang D; Yi B; Cai H; Wang Y; Lou X; Xi Z; Li Z
    Int J Biol Sci; 2021; 17(11):2912-2930. PubMed ID: 34345216
    [No Abstract]   [Full Text] [Related]  

  • 18. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.
    Zhang CL; Zhu KP; Ma XL
    Cancer Lett; 2017 Jun; 396():66-75. PubMed ID: 28323030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.
    Fei D; Yuan H; Zhao M; Zhao D
    Cell Biol Int; 2022 Nov; 46(11):1937-1946. PubMed ID: 36041209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p.
    Wang M; Sun X; Yang Y; Jiao W
    Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.